Axsome Therapeutics (AXSM) Cash from Investing Activities Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -19.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.45% |
| Dec 31, 2025 | 26.80% |
| Sep 30, 2025 | 4.22% |
| Jun 30, 2025 | 93.75% |
| Mar 31, 2025 | -16.46% |
| Dec 31, 2024 | -305.18% |
| Sep 30, 2024 | 29.67% |
| Jun 30, 2024 | -40.18% |
| Mar 31, 2024 | -48.39% |
| Dec 31, 2023 | 29.86% |
| Sep 30, 2023 | -192.37% |
| Jun 30, 2023 | -353.29% |
| Mar 31, 2023 | -96.69% |
| Dec 31, 2022 | -398.51% |
| Sep 30, 2022 | -174.35% |
| Sep 30, 2021 | -212.44% |
| Jun 30, 2021 | -25.11% |
| Mar 31, 2021 | -27.20% |
| Dec 31, 2020 | -2,627.34% |
| Sep 30, 2020 | -60.31% |
| Jun 30, 2020 | 25.07% |
| Mar 31, 2020 | -47.65% |
| Dec 31, 2019 | 37.74% |
| Sep 30, 2019 | 65.26% |
| Sep 30, 2018 | -24.38% |
| Jun 30, 2018 | -89.34% |
| Mar 31, 2018 | -12.43% |